They are a clinical stage biopharmaceutical company focused on applying their proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a.
November 8, 2017
To view the prospectus for IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277